Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | EP300 | Q09472 | 1/20 | 0.39 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.39 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RECQL | P46063 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5487612 | 0.77 | HSD17B10 (0.43) | HSD17B10TDP1ALDH1A1GAAKDM4E | |
| SCHEMBL19382632 | 0.74 | P2RX4 (0.40) | ALDH1A1KDM4ELMNAP2RX4 | |
| SCHEMBL19603574 | 0.69 | P2RX4 (0.39) | MAPTPKMP2RX4SMN1; SMN2NPSR1 | |
| SCHEMBL20837195 | 0.69 | P2RX4 (0.39) | MAPTP2RX4SMN1; SMN2NPSR1 | |
| SCHEMBL30462881 | 0.69 | SMN1; SMN2 (0.47) | HSD17B10ALDH1A1GAAKDM4EEP300 | |
| SCHEMBL5487603 | 0.69 | SMN1; SMN2 (0.47) | HSD17B10ALDH1A1GAAKDM4EEP300 | |
| SCHEMBL28199867 | 0.69 | HSD17B10 (0.56) | HSD17B10TDP1ALDH1A1GAAKDM4E | |
| SCHEMBL20277271 | 0.68 | P2RX4 (0.40) | MAPTP2RX4SMN1; SMN2NPSR1 | |
| SCHEMBL29204149 | 0.68 | HSD17B10 (0.73) | HSD17B10TDP1ALDH1A1GAAKDM4E | |
| SCHEMBL30486192 | 0.68 | HSD17B10 (0.73) | HSD17B10TDP1ALDH1A1GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7176307-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-02-13 | — | — | US | disclosed |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2006-05-18 | — | — | US | disclosed |
| US-7041390-B2 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2006-05-09 | — | — | US | disclosed |
| CN-1751055-A | Organic metal complex, electroluminescent material using the complex and ectroluminescent element using the complex | SEMICONDUCTOR ENERGY LAB (JP) | 2006-03-22 | — | — | CN | disclosed |
| EP-1598361-A1 | ORGANIC METAL COMPLEX, ELECTROLUMINESCENT MATERIAL USING THE COMPLEX AND ECTROLUMINESCENT ELEMENT USING THE COMPLEX | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2005-11-23 | — | — | EP | disclosed |
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050006625-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | HSF1, ELP1, RPL19 | HSD17B10 936/4885TDP1 3827/4885ALDH1A1 264/4885 |
| US-20060106211-A1 | Organometal complex, electroluminescence material using the complex, and electroluminescence element using the complex | ELP1, HSF1, EMC1 | HSD17B10 891/4885TDP1 3277/4885ALDH1A1 227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.